Nitrendipine may increase the hypotensive activities of Captopril. The serum concentration of Nitrendipine can be decreased when it is combined with Deferasirox. The risk or severity of adverse effects can be increased when Miltefosine is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Enalaprilat. The serum concentration of Nitrendipine can be increased when it is combined with Simeprevir. The metabolism of Nitrendipine can be decreased when combined with Clemastine. The metabolism of Nitrendipine can be increased when combined with Pentobarbital. Nitrendipine may increase the hypotensive activities of Lacidipine. The metabolism of Nitrendipine can be decreased when combined with Ticlopidine. The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium Gluceptate. The serum concentration of Fosphenytoin can be increased when it is combined with Nitrendipine. The serum concentration of Simvastatin can be increased when it is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Unoprostone. The serum concentration of Nintedanib can be increased when it is combined with Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Dipyridamole. The serum concentration of Nitrendipine can be increased when it is combined with Fluconazole. The serum concentration of Nitrendipine can be increased when it is combined with Stiripentol. Nialamide may increase the hypotensive activities of Nitrendipine. Nitrendipine may increase the hypotensive activities of Penbutolol. The risk or severity of adverse effects can be increased when Micafungin is combined with Nitrendipine. Perindopril may increase the hypotensive activities of Nitrendipine. Nitrendipine may increase the hypotensive activities of Amifostine. The risk or severity of adverse effects can be increased when Candicidin is combined with Nitrendipine. The metabolism of Nitrendipine can be increased when combined with Thiopental. The risk or severity of adverse effects can be increased when Bifonazole is combined with Nitrendipine. The risk or severity of adverse effects can be increased when Griseofulvin is combined with Nitrendipine. The risk or severity of adverse effects can be increased when Cerulenin is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Cafedrine. Nitrendipine may increase the hypotensive activities of Manidipine. Nitrendipine may increase the hypotensive activities of Carvedilol. The serum concentration of Nitrendipine can be decreased when it is combined with Dabrafenib. Nitrendipine may increase the hypotensive activities of Vincamine. The risk or severity of adverse effects can be increased when Metergoline is combined with Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Bumetanide. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Sevoflurane. Nicorandil may increase the hypotensive activities of Nitrendipine. Phentolamine may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Isoconazole is combined with Nitrendipine. The metabolism of Nitrendipine can be increased when combined with Rifapentine. The risk or severity of adverse effects can be increased when Nystatin is combined with Nitrendipine. The metabolism of Nitrendipine can be decreased when combined with Cobicistat. The risk or severity of adverse effects can be increased when Econazole is combined with Nitrendipine. The serum concentration of Brentuximab vedotin can be increased when it is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Saprisartan. The metabolism of Nitrendipine can be increased when combined with Secobarbital. Molsidomine may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Tolcapone. Brimonidine may increase the antihypertensive activities of Nitrendipine. Indapamide may increase the hypotensive activities of Nitrendipine. The serum concentration of Nitrendipine can be decreased when it is combined with Vemurafenib. Nitrendipine may increase the hypotensive activities of Cicletanine. The serum concentration of Pazopanib can be increased when it is combined with Nitrendipine. The serum concentration of Ledipasvir can be increased when it is combined with Nitrendipine. The metabolism of Nitrendipine can be decreased when combined with Indinavir. The serum concentration of Nitrendipine can be decreased when it is combined with Enzalutamide. The metabolism of Nitrendipine can be increased when combined with Rifampicin. The metabolism of Nitrendipine can be decreased when combined with Rucaparib. Cyclothiazide may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Diclofenamide. Nitrendipine may increase the hypotensive activities of BQ-123. The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium gluconate. The risk or severity of adverse effects can be increased when Nitroxoline is combined with Nitrendipine. The serum concentration of Nitrendipine can be decreased when it is combined with St. John's Wort. The serum concentration of Nitrendipine can be increased when it is combined with Fosaprepitant. Debrisoquin may increase the hypotensive activities of Nitrendipine. Brofaromine may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Propofol. Dapoxetine may increase the orthostatic hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nicergoline is combined with Nitrendipine. Tamsulosin may increase the hypotensive activities of Nitrendipine. Methyldopa may increase the hypotensive activities of Nitrendipine. The serum concentration of Edoxaban can be increased when it is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Selexipag. The metabolism of Nitrendipine can be decreased when combined with Ziprasidone. Moxonidine may increase the hypotensive activities of Nitrendipine. Nitrendipine may increase the hypotensive activities of Cyclopenthiazide. The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium glubionate. Methylphenidate may decrease the antihypertensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Nitric Oxide. Bucindolol may increase the hypotensive activities of Nitrendipine. The serum concentration of Nitrendipine can be decreased when it is combined with Tocilizumab. The risk or severity of adverse effects can be increased when Oxiconazole is combined with Nitrendipine. The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Spirapril. Nitrendipine may increase the hypotensive activities of Bupranolol. Methylene blue may increase the hypotensive activities of Nitrendipine. 7,8-Dichloro-1,2,3,4-tetrahydroisoquinoline may increase the hypotensive activities of Nitrendipine. Dihydralazine may increase the hypotensive activities of Nitrendipine. Nitrendipine may increase the neuromuscular blocking activities of Mivacurium. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Isosorbide Mononitrate. The risk or severity of adverse effects can be increased when Hexetidine is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Tibolone. The therapeutic efficacy of Nitrendipine can be decreased when used in combination with Calcium Chloride. The metabolism of Nitrendipine can be decreased when combined with Atomoxetine. The risk or severity of adverse effects can be increased when Bromocriptine is combined with Nitrendipine. Pivhydrazine may increase the hypotensive activities of Nitrendipine. Trimethaphan may increase the hypotensive activities of Nitrendipine. Mirodenafil may increase the antihypertensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Imipramine is combined with Nitrendipine. The metabolism of Nitrendipine can be decreased when combined with Nelfinavir. The metabolism of Nitrendipine can be decreased when combined with Dihydroergotamine. The risk or severity of adverse effects can be increased when Bafilomycin A1 is combined with Nitrendipine. Amphetamine may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Butenafine is combined with Nitrendipine. The metabolism of Nitrendipine can be decreased when combined with Fosamprenavir. Iproniazid may increase the hypotensive activities of Nitrendipine. Hydracarbazine may increase the hypotensive activities of Nitrendipine. The metabolism of Nitrendipine can be decreased when combined with Atazanavir. The metabolism of Nitrendipine can be decreased when combined with Lovastatin. The metabolism of Nitrendipine can be decreased when combined with Imatinib. Hydrochlorothiazide may increase the hypotensive activities of Nitrendipine. Nitrendipine may increase the hypotensive activities of Zofenopril. The metabolism of Nitrendipine can be decreased when combined with Saquinavir. Ursodeoxycholic acid can cause a decrease in the absorption of Nitrendipine resulting in a reduced serum concentration and potentially a decrease in efficacy. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Dexmedetomidine. The risk or severity of adverse effects can be increased when Trimetrexate is combined with Nitrendipine. Nitrendipine may increase the hypotensive activities of Indenolol. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Acebutolol. The metabolism of Nitrendipine can be decreased when combined with Itraconazole. The metabolism of Nitrendipine can be increased when combined with Lumacaftor. The serum concentration of Nitrendipine can be increased when it is combined with Aprepitant. Nitrendipine may increase the hypotensive activities of Hexamethonium. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Eplerenone. Nitrendipine may increase the hypotensive activities of Niguldipine. The risk or severity of adverse effects can be increased when Mevastatin is combined with Nitrendipine. Vardenafil may increase the antihypertensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Pergolide is combined with Nitrendipine. Bimatoprost may increase the hypotensive activities of Nitrendipine. Safrazine may increase the hypotensive activities of Nitrendipine. The risk or severity of adverse effects can be increased when Nitrendipine is combined with Ropinirole.